These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 33689689)

  • 41. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial.
    Diop A; Daff B; Sow M; Blum J; Diagne M; Sloan NL; Winikoff B
    Lancet Glob Health; 2016 Jan; 4(1):e37-44. PubMed ID: 26718808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.
    Small GW; Rabins PV; Barry PP; Buckholtz NS; DeKosky ST; Ferris SH; Finkel SI; Gwyther LP; Khachaturian ZS; Lebowitz BD; McRae TD; Morris JC; Oakley F; Schneider LS; Streim JE; Sunderland T; Teri LA; Tune LE
    JAMA; 1997 Oct 22-29; 278(16):1363-71. PubMed ID: 9343469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
    Teylan M; Mock C; Gauthreaux K; Chen YC; Chan KCG; Hassenstab J; Besser LM; Kukull WA; Crary JF
    Brain; 2020 Feb; 143(2):611-621. PubMed ID: 31942622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
    Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
    PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.
    Yau WW; Tudorascu DL; McDade EM; Ikonomovic S; James JA; Minhas D; Mowrey W; Sheu LK; Snitz BE; Weissfeld L; Gianaros PJ; Aizenstein HJ; Price JC; Mathis CA; Lopez OL; Klunk WE
    Lancet Neurol; 2015 Aug; 14(8):804-813. PubMed ID: 26139022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Changes in drug management of Alzheimer's disease in nursing homes: Impact of the media campaign against specific drugs for Alzheimer's disease].
    Petit AE; Mangeard H; Chazard E; Puisieux F
    Encephale; 2017 Feb; 43(1):21-26. PubMed ID: 27039155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time to nursing home admission for persons with Alzheimer's disease: the effect of health care system characteristics.
    Miller SC; Prohaska TR; Furner SE; Freels S; Brody JA; Levy PS
    J Gerontol B Psychol Sci Soc Sci; 1998 Nov; 53(6):S341-53. PubMed ID: 9826976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mortality and adverse health events in newly admitted nursing home residents with and without dementia.
    Magaziner J; Zimmerman S; Gruber-Baldini AL; van Doorn C; Hebel JR; German P; Burton L; Taler G; May C; Quinn CC; Port CL; Baumgarten M;
    J Am Geriatr Soc; 2005 Nov; 53(11):1858-66. PubMed ID: 16274365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relative performance of indoor vector control interventions in the Ifakara and the West African experimental huts.
    Oumbouke WA; Fongnikin A; Soukou KB; Moore SJ; N'Guessan R
    Parasit Vectors; 2017 Sep; 10(1):432. PubMed ID: 28927465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study.
    Allan LM; Wheatley A; Smith A; Flynn E; Homer T; Robalino S; Beyer FR; Fox C; Howel D; Barber R; Connolly JA; Robinson L; Parry SW; Rochester L; Corner L; Bamford C
    Health Technol Assess; 2019 Oct; 23(59):1-208. PubMed ID: 31661058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploring social inequalities in healthcare trajectories following diagnosis of diabetes: a state sequence analysis of linked survey and administrative data.
    McKay R; Letarte L; Lebel A; Quesnel-Vallée A;
    BMC Health Serv Res; 2022 Jan; 22(1):131. PubMed ID: 35101054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.
    Reese JP; Hessmann P; Seeberg G; Henkel D; Hirzmann P; Rieke J; Baum E; Dannhoff F; Müller MJ; Jessen F; Geldsetzer MB; Dodel R
    J Alzheimers Dis; 2011; 27(4):723-36. PubMed ID: 21876256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology, diagnosis, and management of Alzheimer's disease and related disorders: implications for minority populations.
    Smyth K; Whitehouse PJ; Rust M; Kahana J
    Health Matrix; 1988-1989 Winter; 6(4):28-32. PubMed ID: 10318201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contextual and individual level factors influencing nutritional program effectiveness in HIV care setting in Tigray region, northern Ethiopia: Mixed methods study.
    Tesfay F; Ziersch A; Mwanri L; Javanparast S
    PLoS One; 2020; 15(4):e0231859. PubMed ID: 32339181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
    Daviglus ML; Bell CC; Berrettini W; Bowen PE; Connolly ES; Cox NJ; Dunbar-Jacob JM; Granieri EC; Hunt G; McGarry K; Patel D; Potosky AL; Sanders-Bush E; Silberberg D; Trevisan M
    NIH Consens State Sci Statements; 2010 Apr; 27(4):1-30. PubMed ID: 20445638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Figuring it out in the moment: a theory of unregulated care providers' knowledge utilization in dementia care settings.
    Janes N; Sidani S; Cott C; Rappolt S
    Worldviews Evid Based Nurs; 2008; 5(1):13-24. PubMed ID: 18333923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.